Previous close | 18.90 |
Open | 18.84 |
Bid | 18.50 x 1000 |
Ask | 18.61 x 900 |
Day's range | 18.56 - 18.92 |
52-week range | 10.84 - 24.58 |
Volume | |
Avg. volume | 2,340,598 |
Market cap | 4.786B |
Beta (5Y monthly) | 0.79 |
PE ratio (TTM) | 4.66 |
EPS (TTM) | 3.99 |
Earnings date | 02 May 2024 |
Forward dividend & yield | 1.12 (5.93%) |
Ex-dividend date | 23 Feb 2024 |
1y target est | 21.75 |
Organon (OGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
JERSEY CITY, N.J., April 08, 2024--Organon To Report First Quarter 2024 Results and Host Conference Call on May 2, 2024
SHANGHAI, China & JERSEY CITY, N.J., April 08, 2024--Organon and Henlius announce that Phase 3 Comparative Clinical Study of Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14 Met Primary Endpoint